Can Results-Based Financing improve health outcomes in resource poor settings? Evidence from Zimbabwe.

Child and maternal health Health financing Heterogeneity Inequality Pay for performance Up to 8): result based financing Zimbabwe

Journal

Social science & medicine (1982)
ISSN: 1873-5347
Titre abrégé: Soc Sci Med
Pays: England
ID NLM: 8303205

Informations de publication

Date de publication:
06 2021
Historique:
revised: 09 03 2021
accepted: 19 04 2021
pubmed: 16 5 2021
medline: 2 7 2021
entrez: 15 5 2021
Statut: ppublish

Résumé

Result Based Financing (RBF) has been implemented in health systems across low and middle-income countries (LMICs), with the objective of improving population health. Most evaluations of RBF schemes have focused on average programme effects for incentivised services. There is limited evidence on the potential effect of RBF on health outcomes, as well as on the heterogeneous effects across socio-economic groups and time periods. This study analyses the effect of Zimbabwe's national RBF scheme on neonatal, infant and under five mortality, using Demographic and Health Survey data from 2005, 2010 and 2015. We use a difference in differences design, which exploits the staggered roll-out of the scheme across 60 districts. We examine average programme effects and perform sub-group analyses to assess differences between socio-economic groups. We find that RBF reduced under-five mortality by two percentage points overall, but that this decrease was only significant for children of mothers with above median wealth (2.7 percentage points) and education (2.1 percentage points). RBF increased institutional delivery by seven percentage points - with a statistically significant effect for poorer socio-economic groups and least educated. We also find that RBF reduced c-section rates by three percentage points. We find no detectable effect of RBF on other incentivised services. When considering programme effects over time, we find that effects were only observed during the second phase of the programme (March 2012) with the exception of c-sections, which only reduced in the longer term. Further research is needed to examine whether these findings can be generalised to other settings.

Identifiants

pubmed: 33991792
pii: S0277-9536(21)00291-4
doi: 10.1016/j.socscimed.2021.113959
pmc: PMC8210646
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113959

Subventions

Organisme : Medical Research Council
ID : MR/S022554/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P014429/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S022554
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Lancet. 2016 Jun 18;387(10037):2521-35
pubmed: 27086174
Lancet. 2011 Apr 23;377(9775):1421-8
pubmed: 21515164
N Engl J Med. 2014 Aug 7;371(6):540-8
pubmed: 25099578
Int J Health Serv. 2018 Jul;48(3):549-561
pubmed: 29932352
Int J Health Plann Manage. 2016 Jul;31(3):309-48
pubmed: 26122744
Health Syst Reform. 2017 Apr 3;3(2):137-147
pubmed: 31514674
Bull World Health Organ. 2011 Feb 1;89(2):153-6
pubmed: 21346927
BMC Public Health. 2016 Apr 14;16:321
pubmed: 27074711
Soc Sci Med. 2014 Dec;123:96-104
pubmed: 25462610
BMC Health Serv Res. 2020 Apr 7;20(1):291
pubmed: 32264888
Glob Health Res Policy. 2019 Jul 15;4:20
pubmed: 31338425
Health Econ. 2016 Jun;25(6):688-705
pubmed: 26224021
Int J Health Policy Manag. 2018 Jan 01;7(7):630-644
pubmed: 29996583
Health Policy Plan. 2014 Aug;29(5):615-21
pubmed: 24134922
Health Aff (Millwood). 2014 Dec;33(12):2179-87
pubmed: 25489036
Health Policy Plan. 2021 Apr 21;36(3):332-340
pubmed: 33491082
BMJ Glob Health. 2018 Jun 27;3(3):e000695
pubmed: 29988988
Glob Health Action. 2019;12(1):1670449
pubmed: 31575331
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD007899
pubmed: 22336833
JAMA Pediatr. 2015 Apr;169(4):349-57
pubmed: 25686357
BMJ Glob Health. 2020 Aug;5(8):
pubmed: 32784210
Lancet. 2016 Jul 16;388(10041):268-74
pubmed: 27207746
Soc Sci Med. 2021 Feb;270:113624
pubmed: 33373774
Health Aff (Millwood). 2011 Dec;30(12):2427-36
pubmed: 22147872
Health Policy Plan. 2021 Jun 25;36(6):835-847
pubmed: 33963406
Glob Health Res Policy. 2019 Jan 31;4:3
pubmed: 30734000
Implement Sci. 2017 Feb 2;12(1):10
pubmed: 28148305
N Engl J Med. 2012 Apr 26;366(17):1606-15
pubmed: 22455751
Int J Equity Health. 2018 Jan 29;17(1):14
pubmed: 29378658

Auteurs

Eleonora Fichera (E)

Department of Economics, University of Bath, 2.11 - 3 East, Claverton Down Road, BA2 7AY, Bath, UK. Electronic address: e.fichera@bath.ac.uk.

Laura Anselmi (L)

Health, Organisation, Policy and Economics, Division of Population Health, Health Services Research and Primary Care, University of Manchester, UK.

Gwati Gwati (G)

Zimbabwe Ministry of Health and Child Care, Zimbabwe.

Garrett Brown (G)

School of Politics and International Studies, University of Leeds, UK.

Roxanne Kovacs (R)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, UK.

Josephine Borghi (J)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH